Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers (Major) | 90 | 7.7% |
| Current Price (06/05) | $147.30 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 82,729.0 | |||
| Sales Growth Forecast | 4.1% | |||
| Net Profit Margin | 30.0% | |||
| Projected Shares Outstanding | 2,575.11 | |||
| EPS - Five year Forecast | $11.78 | |||
| Average P/E Ratio | 16.0 | |||
| Projected Average Price | $188.47 | |||
| Price Appreciation (Annualized) | 5.1% | |||
| Annual Dividend Yield | 2.6% | |||
| Projected Annual Return | 7.7% | |||
| Quality | ||||
| Financial Strength | 99 | 24.8 | ||
| EPS Stability | 92 | 22.9 | ||
| Industry Sales Growth Rate | 8.0% | 6.4 | ||
| Industry Net Profit Margin | 22.5% | 16.7 | ||
| Calculated Quality Rating | 70.8 | |||
| Fool CAPS | ||||
Total Players
13569
Outperforms
507
Underperforms
All-Stars (2916)
2851
Outperforms (98%)
65
Underperforms
|
||||
| Fundamental Data Updated: 05/15/2020 | ||||